DK396885A - Kemiske forbindelser med beta-blokker-aktivitet, fremgangsmaade til deres fremstilling, kompositioner indeholdende forbindelserne og forbindelsernes anvendelse inden for medicinen - Google Patents

Kemiske forbindelser med beta-blokker-aktivitet, fremgangsmaade til deres fremstilling, kompositioner indeholdende forbindelserne og forbindelsernes anvendelse inden for medicinen Download PDF

Info

Publication number
DK396885A
DK396885A DK396885A DK396885A DK396885A DK 396885 A DK396885 A DK 396885A DK 396885 A DK396885 A DK 396885A DK 396885 A DK396885 A DK 396885A DK 396885 A DK396885 A DK 396885A
Authority
DK
Denmark
Prior art keywords
relations
beta
medicine
procedures
preparation
Prior art date
Application number
DK396885A
Other languages
Danish (da)
English (en)
Other versions
DK396885D0 (da
Inventor
Geoffrey Allan
Donald Bull
George William Hardy
Grahame Roy Lee
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of DK396885D0 publication Critical patent/DK396885D0/da
Publication of DK396885A publication Critical patent/DK396885A/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/022Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2
    • C07K5/0222Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2 with the first amino acid being heterocyclic, e.g. Pro, Trp
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/16Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
DK396885A 1984-09-01 1985-08-30 Kemiske forbindelser med beta-blokker-aktivitet, fremgangsmaade til deres fremstilling, kompositioner indeholdende forbindelserne og forbindelsernes anvendelse inden for medicinen DK396885A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB848422165A GB8422165D0 (en) 1984-09-01 1984-09-01 Compounds

Publications (2)

Publication Number Publication Date
DK396885D0 DK396885D0 (da) 1985-08-30
DK396885A true DK396885A (da) 1986-03-02

Family

ID=10566163

Family Applications (1)

Application Number Title Priority Date Filing Date
DK396885A DK396885A (da) 1984-09-01 1985-08-30 Kemiske forbindelser med beta-blokker-aktivitet, fremgangsmaade til deres fremstilling, kompositioner indeholdende forbindelserne og forbindelsernes anvendelse inden for medicinen

Country Status (16)

Country Link
EP (1) EP0174162A3 (zh)
JP (1) JPS6183198A (zh)
KR (1) KR860002501A (zh)
AU (1) AU581455B2 (zh)
CS (1) CS621585A2 (zh)
DD (1) DD236522A5 (zh)
DK (1) DK396885A (zh)
ES (6) ES8703418A1 (zh)
FI (1) FI853336L (zh)
GB (1) GB8422165D0 (zh)
GR (1) GR852113B (zh)
HU (1) HUT39190A (zh)
MC (1) MC1695A1 (zh)
PL (3) PL255192A1 (zh)
PT (1) PT81055B (zh)
ZA (1) ZA856672B (zh)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK103487A (da) * 1986-02-28 1987-08-29 Wellcome Found Forbindelser der paa samme tid er beta-blokkere og ace-inhibitorer
AU6953687A (en) * 1986-02-28 1987-09-03 Wellcome Foundation Limited, The Subst alanyl-proline compounds as beta-andrenergic blocking compounds
US5036051A (en) * 1987-10-06 1991-07-30 Abbott Laboratories Glaucoma treatment
US4927807A (en) * 1987-10-06 1990-05-22 Abbott Laboratories Glaucoma treatment
US5346887A (en) * 1987-10-06 1994-09-13 Abbott Laboratories Glaucoma treatment
US5025001A (en) * 1988-06-15 1991-06-18 Brigham And Women's Hospital S-nitroso derivatives of ACE inhibitors and the use thereof
US5187183A (en) * 1988-06-15 1993-02-16 Brigham & Women's Hospital S-nitroso derivatives of ACE inhibitors and the use thereof
US5356890A (en) * 1988-06-15 1994-10-18 Brigham And Women's Hospital S-nitroso derivatives of ace inhibitors and the use thereof
US5059589A (en) * 1988-09-08 1991-10-22 Abbott Laboratories Glaucoma treatment
US4916129A (en) * 1989-01-19 1990-04-10 E. I. Du Pont De Nemours And Company Combination β-blocking/angiotensin II blocking antihypertensives
US9259535B2 (en) 2006-06-22 2016-02-16 Excelsior Medical Corporation Antiseptic cap equipped syringe
US11229746B2 (en) 2006-06-22 2022-01-25 Excelsior Medical Corporation Antiseptic cap
US9078992B2 (en) 2008-10-27 2015-07-14 Pursuit Vascular, Inc. Medical device for applying antimicrobial to proximal end of catheter
US10166381B2 (en) 2011-05-23 2019-01-01 Excelsior Medical Corporation Antiseptic cap
ES2797649T3 (es) 2011-07-12 2020-12-03 Icu Medical Inc Dispositivo para entrega de agente antimicrobiano en un catéter transdérmico
WO2015168677A1 (en) 2014-05-02 2015-11-05 Excelsior Medical Corporation Strip package for antiseptic cap
AU2016262400B2 (en) 2015-05-08 2021-01-21 Icu Medical, Inc. Medical connectors configured to receive emitters of therapeutic agents
ES2929769T3 (es) 2016-10-14 2022-12-01 Icu Medical Inc Tapas desinfectantes para conectores médicos
WO2018204206A2 (en) 2017-05-01 2018-11-08 Icu Medical, Inc. Medical fluid connectors and methods for providing additives in medical fluid lines
US11400195B2 (en) 2018-11-07 2022-08-02 Icu Medical, Inc. Peritoneal dialysis transfer set with antimicrobial properties
US11541221B2 (en) 2018-11-07 2023-01-03 Icu Medical, Inc. Tubing set with antimicrobial properties
US11541220B2 (en) 2018-11-07 2023-01-03 Icu Medical, Inc. Needleless connector with antimicrobial properties
US11517732B2 (en) 2018-11-07 2022-12-06 Icu Medical, Inc. Syringe with antimicrobial properties
US11534595B2 (en) 2018-11-07 2022-12-27 Icu Medical, Inc. Device for delivering an antimicrobial composition into an infusion device
EP3883638A1 (en) 2018-11-21 2021-09-29 ICU Medical, Inc. Antimicrobial device comprising a cap with ring and insert
CA3204371A1 (en) 2020-12-07 2022-06-16 Icu Medical, Inc. Peritoneal dialysis caps, systems and methods

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3705907A (en) * 1970-02-19 1972-12-12 Sandoz Ltd 4-(2-hydroxy)-3-aminopropoxy)-indole derivatives
IL58849A (en) * 1978-12-11 1983-03-31 Merck & Co Inc Carboxyalkyl dipeptides and derivatives thereof,their preparation and pharmaceutical compositions containing them
FR2503155A2 (fr) * 1980-10-02 1982-10-08 Science Union & Cie Nouveaux imino diacides substitues, leurs procedes de preparation et leur emploi comme inhibiteur d'enzyme
EP0278530A3 (de) * 1980-08-30 1989-08-02 Hoechst Aktiengesellschaft Aminosäurederivate, Verfahren zu ihrer Herstellung, diese enthaltende Mittel und deren Verwendung
GR75019B (zh) * 1980-09-17 1984-07-12 Univ Miami
US4344949A (en) * 1980-10-03 1982-08-17 Warner-Lambert Company Substituted acyl derivatives of 1,2,3,4-tetrahydroisoquinoline-3-carboxylic acids
US4462943A (en) * 1980-11-24 1984-07-31 E. R. Squibb & Sons, Inc. Carboxyalkyl amino acid derivatives of various substituted prolines
EP0080822A1 (en) * 1981-11-27 1983-06-08 Beecham Group Plc Anti-hypertensive prolinol-based peptides
IE55867B1 (en) * 1981-12-29 1991-02-14 Hoechst Ag New derivatives of bicyclic aminoacids,processes for their preparation,agents containing these compounds and their use,and new bicyclic aminoacids as intermediates and processes for their preparation
DE3360065D1 (en) * 1982-03-08 1985-03-28 Schering Corp Carboxyalkyl dipeptides, processes for their production and pharmaceutical compositions containing them
AU560285B2 (en) * 1982-07-19 1987-04-02 Imperial Chemical Industries Plc Heterocyclyl carbonyl sulphonamides

Also Published As

Publication number Publication date
EP0174162A3 (en) 1988-07-27
PL265522A1 (en) 1988-05-12
ES8801672A1 (es) 1988-02-16
ES8801311A1 (es) 1987-12-16
PL265523A1 (en) 1988-02-04
GB8422165D0 (en) 1984-10-03
FI853336L (fi) 1986-03-02
ZA856672B (en) 1987-05-27
JPS6183198A (ja) 1986-04-26
KR860002501A (ko) 1986-04-26
FI853336A0 (fi) 1985-08-30
AU4693285A (en) 1986-03-06
PL255192A1 (en) 1987-09-21
PT81055B (en) 1987-07-02
ES553612A0 (es) 1987-12-16
ES8801313A1 (es) 1988-01-01
HUT39190A (en) 1986-08-28
ES553613A0 (es) 1988-01-01
CS621585A2 (en) 1989-08-14
PT81055A (en) 1985-09-01
ES8801312A1 (es) 1987-12-16
MC1695A1 (fr) 1986-07-18
AU581455B2 (en) 1989-02-23
ES553614A0 (es) 1988-02-16
GR852113B (zh) 1985-12-24
ES8801310A1 (es) 1988-01-01
DD236522A5 (de) 1986-06-11
ES553611A0 (es) 1987-12-16
ES553610A0 (es) 1988-01-01
ES8703418A1 (es) 1987-02-16
DK396885D0 (da) 1985-08-30
EP0174162A2 (en) 1986-03-12
ES546595A0 (es) 1987-02-16

Similar Documents

Publication Publication Date Title
DK396885D0 (da) Kemiske forbindelser med beta-blokker-aktivitet, fremgangsmaade til deres fremstilling, kompositioner indeholdende forbindelserne og forbindelsernes anvendelse inden for medicinen
DK87886A (da) Thiazolidinderivater, deres fremstilling og anvendelse
DK273689A (da) 4-amino-3-carboxyquinoliner og -naphthyridiner, fremgangsmaade til deres fremstilling og anvendelse deraf i laegemidler
NO862095L (no) Farmasoeytiske preparater inneholdende vevsplasmnogenaktivitator og fremgangsmaate for deres fremstilling.
DK129386D0 (da) Iodpropargylethere, deres fremstilling og anvendelse
DK493386A (da) Benzimidazoler, -oxazoler og -thiazoler, deres anvendelse i farmaceutiske kompositioner og fremgangsmaade til forbindelsernes fremstilling
DK158522C (da) Beta-amylase, samt fremstilling og anvendelse deraf
DK519586A (da) 1-aryl-4-nitro-pyrazoler, deres fremstilling og anvendelse
DK385185A (da) Substituerede phenylurinstoffer, deres fremstilling og anvendelse
DK470286D0 (da) Cementholdige tilslagsstoffer og deres anvendelse
DK133587D0 (da) 2-heterocyclylthio-penemer, deres anvendelse og farmaceutisk komposition indeholdende forbindelserne
DK399985D0 (da) 6-substituerede mitomycin-analoge, deres anvendelse inden for medicinen og kompositioner indeholdende forbindelserne
DK420986D0 (da) Dihydropyridin-2-hydroxyaminer, fremgangsmaade til deres fremstilling og deres anvendelse i laege-midler
DK380286D0 (da) Sulfonamider, deres fremstilling og anvendelse
DK487986A (da) Mikrobiologisk fremstillet d(-)-mandelat-dehydrogenase, fremgangsmaade til dets fremstilling og dets anvendelse
DK617886A (da) 1-aryl-pyrazoler, deres fremstilling og anvendelse
DK396886D0 (da) Gem-dihalogen-1,8-diamino-4-azaoctaner, deres fremstilling og anvendelse
DK402585A (da) Pseudooligosaccharider med alfa-glucosidase-inhiberende virkning, deres fremstilling og anvendelse samt farmaceutiske praeparater
DK377786D0 (da) 1-aryl-5-hydrazino-pyrazoler, deres fremstilling og anvendelse
TR22548A (tr) Sulfonilguanidinotriazin tuerevleri,hazirlanmalarina mahsus usuller ve herbisid olarak kullanilmalari
DK292685D0 (da) Thiazolidinderivater og fremgangsmaader til fremstilling deraf
DK564986D0 (da) Thienylurinstofderivater, deres fremstilling og anvendelse
DK478586D0 (da) Polyhydroxyalkyl-oligourinstoffer og deres anvendelse
DK393986A (da) Lactamamider, deres fremstilling og anvendelse
DK401486D0 (da) Diazaphosphoriner, deres fremstilling og anvendelse til bekaempelse afskadelige organismer

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment